At the conclusion of this presentation, attendees are expected to: [1] Understand unique features, pathology, and management of severe SARS CoV2 associated disease in children, [2] Discuss the immune pathology and treatment of SARS CoV2 associated Multisystem Inflammatory Syndrome in Children (MIS C), [3] Review genetic changes associated with MIS-C